The US Centers for Medicare and Medicaid Services’ plan to champion and facilitate multi-state outcomes-based contracts for cell and gene therapies in Medicaid as part of a demonstration project reflects the concern that states can’t go it alone, according to a Health and Human Services Department report.
The demonstration on cell and gene therapy is one of three announced by CMS that will be implemented in the...








